Assessment of PI3 kinase as a druggable target in melanoma

被引：0
|
作者：
Aziz, S. A.
Pick-Golan, E.
McCarthy, M. M.
Flaherty, K. T.
Camp, R. L.
Rimm, D. L.
Kluger, H. M.
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8521
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Killing Tumors by Keeping Ras and PI3′ Kinase Apart
    Yuan, Tina L.
    McCormick, Frank
    CANCER CELL, 2013, 24 (05) : 562 - 563
  • [42] PI3 kinase mutations occur early in breast carcinoma
    Dunlap, J. B.
    Le, C.
    Patterson, J.
    Town, A.
    Heinrich, M. C.
    Corless, C. L.
    Troxell, M. L.
    LABORATORY INVESTIGATION, 2007, 87 : 29A - 29A
  • [43] Selective Inhibition of Retinal Angiogenesis by Targeting PI3 Kinase
    Alvarez, Yolanda
    Astudillo, Olaya
    Jensen, Lasse
    Reynolds, Alison L.
    Waghorne, Nora
    Brazil, Derek P.
    Cao, Yihai
    O'Connor, John J.
    Kennedy, Breandan N.
    PLOS ONE, 2009, 4 (11):
  • [44] PI3 kinase mutations occur early in breast carcinoma
    Dunlap, J. B.
    Le, C.
    Patterson, J.
    Town, A.
    Heinrich, M. C.
    Corless, C. L.
    Troxell, M. L.
    MODERN PATHOLOGY, 2007, 20 : 29A - 29A
  • [45] Preconditioning with isoproterenol is dependent on PKB/PI3 kinase activation
    Moolman, J
    Salie, R
    Lochner, A
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (06) : 1047 - 1047
  • [46] Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
    Ksionda, Olga
    Mues, Marsilius
    Wandler, Anica M.
    Donker, Lisa
    Tenhagen, Milou
    Jun, Jesse
    Ducker, Gregory S.
    Matlawska-Wasowska, Ksenia
    Shannon, Kevin
    Shokat, Kevan M.
    Roose, Jeroen P.
    PLOS ONE, 2018, 13 (05):
  • [47] The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance
    Parkman, Gennie L.
    Foth, Mona
    Kircher, David A.
    Holmen, Sheri L.
    McMahon, Martin
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (01) : 43 - 56
  • [48] Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
    Baselga, Jose
    ONCOLOGIST, 2011, 16 : 12 - 19
  • [49] Activation of MAP kinase by MC4-R through PI3 kinase
    Vongs, A
    Lynn, NM
    Rosenblum, CI
    REGULATORY PEPTIDES, 2004, 120 (1-3) : 113 - 118
  • [50] Discovery of the Potent Phosphoinositide 3-Kinase δ (PI3 K δ) Inhibitors
    Lei, Tao
    Hong, Yongwei
    Chang, Xinyue
    Zhang, Zhimin
    Liu, Xingguo
    Hu, Miao
    Huang, Wenhai
    Yang, Haiyan
    CHEMISTRYSELECT, 2020, 5 (01): : 196 - 200
12345